Literature DB >> 32016678

Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution.

Estelle Yau1,2, Andrés Olivares-Morales3, Michael Gertz2, Neil Parrott2, Adam S Darwich1,4, Leon Aarons2, Kayode Ogungbenro2.   

Abstract

In physiologically based pharmacokinetic (PBPK) modelling, the large number of input parameters, limited amount of available data and the structural model complexity generally hinder simultaneous estimation of uncertain and/or unknown parameters. These parameters are generally subject to estimation. However, the approaches taken for parameter estimation vary widely. Global sensitivity analyses are proposed as a method to systematically determine the most influential parameters that can be subject to estimation. Herein, a global sensitivity analysis was conducted to identify the key drug and physiological parameters influencing drug disposition in PBPK models and to potentially reduce the PBPK model dimensionality. The impact of these parameters was evaluated on the tissue-to-unbound plasma partition coefficients (Kpus) predicted by the Rodgers and Rowland model using Latin hypercube sampling combined to partial rank correlation coefficients (PRCC). For most drug classes, PRCC showed that LogP and fraction unbound in plasma (fup) were generally the most influential parameters for Kpu predictions. For strong bases, blood:plasma partitioning was one of the most influential parameter. Uncertainty in tissue composition parameters had a large impact on Kpu and Vss predictions for all classes. Among tissue composition parameters, changes in Kpu outputs were especially attributed to changes in tissue acidic phospholipid concentrations and extracellular protein tissue:plasma ratio values. In conclusion, this work demonstrates that for parameter estimation involving PBPK models and dimensionality reduction purposes, less influential parameters might be assigned fixed values depending on the parameter space, while influential parameters could be subject to parameters estimation.

Entities:  

Keywords:  PBPK; drug distribution; global sensitivity analysis; partition coefficients; uncertainty

Year:  2020        PMID: 32016678     DOI: 10.1208/s12248-020-0418-7

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  62 in total

Review 1.  Lipophilicity in PK design: methyl, ethyl, futile.

Authors:  H van de Waterbeemd; D A Smith; B C Jones
Journal:  J Comput Aided Mol Des       Date:  2001-03       Impact factor: 3.686

2.  Robust assessment of statistical significance in the use of unbound/intrinsic pharmacokinetic parameters in quantitative structure-pharmacokinetic relationships with lipophilicity.

Authors:  A M Davis; P J Webborn; D W Salt
Journal:  Drug Metab Dispos       Date:  2000-02       Impact factor: 3.922

3.  In silico prediction of aqueous solubility, human plasma protein binding and volume of distribution of compounds from calculated pKa and AlogP98 values.

Authors:  Mario Lobell; Vinothini Sivarajah
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

4.  A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals.

Authors:  Thomas Peyret; Patrick Poulin; Kannan Krishnan
Journal:  Toxicol Appl Pharmacol       Date:  2010-09-30       Impact factor: 4.219

5.  Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

Authors:  Trudy Rodgers; Malcolm Rowland
Journal:  J Pharm Sci       Date:  2006-06       Impact factor: 3.534

6.  Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis.

Authors:  M Paul Gleeson
Journal:  J Med Chem       Date:  2007-01-11       Impact factor: 7.446

7.  Accounting for inter-correlation between enzyme abundance: a simulation study to assess implications on global sensitivity analysis within physiologically-based pharmacokinetics.

Authors:  Nicola Melillo; Adam S Darwich; Paolo Magni; Amin Rostami-Hodjegan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-03-23       Impact factor: 2.745

8.  Physiologically based pharmacokinetic modeling in regulatory decision-making at the European Medicines Agency.

Authors:  E Luzon; K Blake; S Cole; A Nordmark; C Versantvoort; E Gil Berglund
Journal:  Clin Pharmacol Ther       Date:  2016-12-26       Impact factor: 6.875

9.  QSAR models for the prediction of plasma protein binding.

Authors:  Taravat Ghafourian; Zeshan Amin
Journal:  Bioimpacts       Date:  2013-02-21

10.  Species variations in phospholipid class distribution of organs. I. Kidney, liver and spleen.

Authors:  G Rouser; G Simon; G Kritchevsky
Journal:  Lipids       Date:  1969-11       Impact factor: 1.880

View more
  6 in total

1.  Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically-based pharmacokinetic modelling approach.

Authors:  Jeffry Adiwidjaja; Alan V Boddy; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2020-05-13       Impact factor: 4.335

Review 2.  Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty.

Authors:  Ali Aykut Akalın; Barış Dedekargınoğlu; Sae Rome Choi; Bumsoo Han; Altug Ozcelikkale
Journal:  Pharm Res       Date:  2022-06-01       Impact factor: 4.580

3.  Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug Discovery.

Authors:  Doha Naga; Neil Parrott; Gerhard F Ecker; Andrés Olivares-Morales
Journal:  Mol Pharm       Date:  2022-04-27       Impact factor: 5.364

4.  Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical Compounds.

Authors:  Neha Murad; Kishore K Pasikanti; Benjamin D Madej; Amanda Minnich; Juliet M McComas; Sabrinia Crouch; Joseph W Polli; Andrew D Weber
Journal:  Drug Metab Dispos       Date:  2020-11-25       Impact factor: 3.922

5.  Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled Compounds.

Authors:  Nicola Melillo; Silvia Grandoni; Nicola Cesari; Giandomenico Brogin; Paola Puccini; Paolo Magni
Journal:  AAPS J       Date:  2020-08-30       Impact factor: 4.009

6.  A latent variable approach to account for correlated inputs in global sensitivity analysis.

Authors:  Nicola Melillo; Adam S Darwich
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-05-25       Impact factor: 2.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.